NEW YORK (GenomeWeb News) – Investment bank Thomas Weisel Partners has increased its fourth-quarter and full-year 2009 revenue guidance for Affymetrix, two weeks before the firm is scheduled to report its results.

Analyst Peter Lawson said that the bank has increased its Q4 estimate to $83 million from its previous estimate of $82 million, slightly above analysts' consensus estimate of $82.8 million. It also lowered the firm's loss per share to $.10 from $.11, in line with the consensus estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.